1. 2002
  2. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies

    Quivy, V., Adam, E., Collette, Y., Demonte, D., Chariot, A., Vanhulle, C., Berkhout, B., Castellano, R., de Launoit, Y., Burny, A., Piette, J., Bours, V. & van Lint, C., 2002, In: Journal of virology. 76, 21, p. 11091-11103

    Research output: Contribution to journalArticleAcademicpeer-review

  3. The genetic diversity of HIV-1 and its implications for vaccine development

    Lukashov, V. V., Goudsmit, J. & Paxton, W. A., 2002, AIDS vaccine research. Wong-Staal, F. & Gallo, R. C. (eds.). New York-Basel: Marcel Dekker Inc., p. 93-120

    Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

  4. The Helicobacter pylori homologue of the ferric uptake regulator is involved in acid resistance

    Bijlsma, J. J. E., Waidner, B., Vliet, A. H. M. V., Hughes, N. J., Häg, S., Bereswill, S., Kelly, D. J., Vandenbroucke-Grauls, C. M. J. E., Kist, M. & Kusters, J. G., 2002, In: Infection and immunity. 70, 2, p. 606-611

    Research output: Contribution to journalArticleAcademicpeer-review

  5. The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins

    Beljaars, L., Floris, R., Berkhout, B., Smit, C., Meijer, D. K. F. & Molema, G., 2002, In: Biochemical pharmacology. 63, 9, p. 1663-1673

    Research output: Contribution to journalArticleAcademicpeer-review

  6. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120

    Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D. & Moore, J. P., 2002, In: Journal of virology. 76, 14, p. 7293-7305

    Research output: Contribution to journalArticleAcademicpeer-review

  7. The role of the Ferric Uptake Regulator (Fur) in regulation of Helicobacter pylori iron uptake

    van Vliet, A. H. M., Stoof, J., Vlasblom, R., Wainwright, S. A., Hughes, N. J., Kelly, D. J., Bereswill, S., Bijlsma, J. J. E., Hoogenboezem, T., Vandenbroucke-Grauls, C. M. J. E., Kist, M., Kuipers, E. J. & Kusters, J. G., 2002, In: Helicobacter. 7, 4, p. 237-244

    Research output: Contribution to journalArticleAcademicpeer-review

  8. The stool antigen test for detection of Helicobacter pylori after eradication therapy

    Vaira, D., Vakil, N., Menegatti, M., van't Hoff, B., Ricci, C., Gatta, L., Gasbarrini, G., Quina, M., Pajares Garcia, J. M., van der Ende, A., van der Hulst, R., Anti, M., Duarte, C., Gisbert, J. P., Miglioli, M. & Tytgat, G., 2002, In: Annals of internal medicine. 136, 4, p. 280-287

    Research output: Contribution to journalArticleAcademicpeer-review

  9. The tRNA primer activation signal in the human immunodeficiency virus type 1 genome is important for initiation and processive elongation of reverse transcription

    Beerens, N. & Berkhout, B., 2002, In: Journal of virology. 76, 5, p. 2329-2339

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model

    Lettinga, K. D., Florquin, S., Speelman, P., van Ketel, R., van der Poll, T. & Verbon, A., 2002, In: Journal of infectious diseases. 186, 4, p. 570-573

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Transcriptional phase variation of a type III restriction-modification system in Helicobacter pylori

    de Vries, N., Duinsbergen, D., Kuipers, E. J., Pot, R. G. J., Wiesenekker, P., Penn, C. W., van Vliet, A. H. M., Vandenbroucke-Grauls, C. M. J. E. & Kusters, J. G., 2002, In: Journal of bacteriology. 184, 23, p. 6615-6623

    Research output: Contribution to journalArticleAcademicpeer-review

ID: 19727